As of September 2026, Longview Advantage ETF is classified as not halal.
NOT HALAL
Is Longview Advantage ETF Halal?
Shariah Compliance Analysis of EBI ETF
US Equity Total Market
No. As of September 2026, Longview Advantage ETF (EBI) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Longview Advantage ETF does not pass Musaffa's business and financial screening criteria.
EBI was created on 2025-02-25 by Longview. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 580.72m in AUM and 1744 holdings. EBI is an actively managed fund of US companies selected for their high profitability-to-value ratio.
Longview Advantage ETF (EBI) Chart
Key Statistics of Longview Advantage ETF (EBI)
Today's Open
-
AUM
-
Avg. Volume
-
Expense Ratio
-
P/E Ratio
-
P/B Ratio
-
FAQ's for Longview Advantage ETF (EBI)
As of September 2026, Longview Advantage ETF EBI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Longview Advantage ETF using these criteria to determine its compliance status.
The Shariah compliance status of Longview Advantage ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Longview Advantage ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.